×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| BAL PHARMA LTD. | 663.76 | 3.23 | 656.35 | 0.2 | 141.0 | 19.7 |
| TYCHE INDUSTRIES LTD. | NA | NA | NA | NA | 139 | 11.5 |
| DENIS CHEM LAB LTD | NA | NA | NA | NA | 137 | 16.1 |
Bal Pharma Ltd., with Security Code 524824, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 82.0 | 70.2 | 92.3 | 81.5 | 94.6 | 73.1 | 74.7 | 72.9 | 81.8 | 65.6 |
| Expenses | 73.7 | 63.3 | 84.6 | 73.9 | 84.3 | 66.1 | 67.2 | 65.2 | 73.9 | 59.5 |
| Operating Profit | 8.3 | 6.8 | 7.7 | 7.6 | 10.3 | 7.1 | 7.5 | 7.7 | 7.9 | 6.2 |
| OPM % | 10.09% | 9.75% | 8.29% | 9.36% | 10.91% | 9.67% | 10.01% | 10.6% | 9.65% | 9.37% |
| Other Income | 0.4 | 0.4 | 0.4 | 0.3 | 2.2 | 0.8 | 0.4 | 0.8 | 1.0 | 0.7 |
| Interest | 3.8 | 3.6 | 3.8 | 3.7 | 4.1 | 3.7 | 4.2 | 5.0 | 3.9 | 4.1 |
| Depreciation | 1.7 | 2.1 | 2.0 | 2.6 | 1.8 | 2.1 | 2.1 | 2.3 | 2.1 | 2.5 |
| Profit before tax | 3.2 | 1.5 | 2.2 | 1.7 | 6.7 | 2.1 | 1.5 | 1.2 | 2.9 | 0.3 |
| Tax % | -33.9% | -21.9% | -28.2% | -24.9% | -6.8% | 17% | 20.8% | -4% | 95.9% | 0% |
| Net Profit | 2.1 | 1.2 | 1.6 | 1.3 | 6.2 | 1.7 | 1.2 | 1.2 | 5.6 | 0.3 |
| EPS in Rs | 1.36 | 0.76 | 1.02 | 0.8 | 4.18 | 1.11 | 0.76 | 0.73 | 0 | 0.2 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 76.6 | 82.5 | 70.4 | 92.5 | 81.7 | 94.6 | 74.4 | 73.7 | 73.2 | 81.9 |
| Expenses | 70.5 | 74.3 | 63.9 | 84.8 | 73.9 | 85.0 | 67.9 | 66.0 | 65.4 | 74.2 |
| Operating Profit | 6.2 | 8.2 | 6.4 | 7.7 | 7.8 | 9.6 | 6.5 | 7.7 | 7.8 | 7.7 |
| OPM % | 8.03% | 9.9% | 9.15% | 8.32% | 9.55% | 10.14% | 8.69% | 10.44% | 10.6% | 9.41% |
| Other Income | 0.5 | 0.2 | 0.2 | 0.1 | 0.1 | 2.5 | 0.8 | -0.2 | 0.5 | 1.1 |
| Interest | 3.1 | 3.9 | 3.6 | 3.8 | 3.7 | 4.1 | 4.2 | 3.7 | 5.0 | 4.0 |
| Depreciation | 2.4 | 2.1 | 2.5 | 2.4 | 3.0 | 2.2 | 2.4 | 2.5 | 2.7 | 2.2 |
| Profit before tax | 1.1 | 2.4 | 0.4 | 1.6 | 1.3 | 5.8 | 0.6 | 1.4 | 0.6 | 2.7 |
| Tax % | -43.9% | -32.9% | -78% | -39.4% | -32.9% | -3.8% | -57.9% | -23.5% | -8.5% | 107.9% |
| Net Profit | 0.6 | 1.6 | 0.1 | 1.0 | 0.8 | 5.5 | 0.3 | 1.0 | 0.5 | 5.4 |
| EPS in Rs | 0.38 | 1.04 | 0.06 | 0.62 | 0.54 | 3.74 | 0.16 | 0.65 | 0.33 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 9% |
| 3 Years: | 11% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 9% |
| 3 Years: | 4% |
| TTM: | 67% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 22% |
| 3 Years: | -1% |
| 1 Year: | -3% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 9% |
| 3 Years: | 11% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 28% |
| 3 Years: | 16% |
| TTM: | 108% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 22% |
| 3 Years: | -1% |
| 1 Year: | -3% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|